Insulin signaling and insulin resistance;Signalisation insulinique et résistance à l'insuline

Therapie

Volumn 62, Issue 4, 2007, Pages 277-284

  Ferré, Pascal ^a,b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Insulin; Insulin resistance; Lipids; Obesity; Type 2 diabetes

Indexed keywords

FATTY ACID; INSULIN; INSULIN RECEPTOR;

CONFERENCE PAPER; DIABETIC OBESITY; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; LIPID METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 38449091580     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2007052     Document Type: Conference Paper

References (22)

1. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806
2. White MF. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog Horm Res 1998; 53: 119-38
3. Avruch J, Hara K, Lin Y, et al. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 2006; 25: 6361-72
4. Eberle D, Hegarty B, Bossard P, et al. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004; 86: 839-48
5. Mounier C, Posner BI. Transcriptional regulation by insulin: from the receptor to the gene. Can J Physiol Pharmacol 2006; 84: 713-24
6. Kanzaki M. Insulin receptor signals regulating GLUT4 translocation and actin dynamics. Endocr J 2006; 53: 267-93
7. Ishiki M, Klip A. Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 2005; 146: 5071-8
8. Farese RV, Sajan MP, Standaert ML. Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans 2005; 33: 350-3
9. Bryant NJ, Govers R, James DE. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 2002; 3: 267-77
10. Knutson VP. Cellular trafficking and processing of the insulin receptor. Faseb J 1991; 5: 2130-8
11. Asante-Appiah E, Kennedy BP. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am J Physiol Endocrinol Metab 2003; 284: E 663-70
12. Vinciguerra M, Foti M. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling. Arch Physiol Biochem 2006; 112: 89-104
13. Capeau J. Insulin signaling: mechanisms altered in insulin resistance. Med Sci (Paris) 2003; 19: 834-9
14. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006; 119: S10-6
15. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859-65
16. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270-4
17. Summers SA Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006; 45: 42-72
18. Le Marchand-Brustel Y, Gual P, Gremeaux T, et al. Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochem Soc Trans 2003; 31: 1152-6
19. Kahn BB, Alquier T, Carling D, et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell metabolism 2004; 1: 15-25
20. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-95
21. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-74
22. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004; 53 Suppl 1: S43-50